Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Przemioslo

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Endoscopy|January 9, 2001
The effects of a preassessment clinic on nonattendance rates for day-case colonoscopyJ A Tibble, I Forgacs, I Bjarnason, et al.
Annals of Clinical Biochemistry|February 17, 1998
The effect of benign and malignant liver disease on the tumour markers CA19-9 and CEAS Maestranzi, R Przemioslo, H Mitchell, et al.
Gut|January 1, 1995
Analysis of crypt cell proliferation in coeliac disease using MI-B1 antibody shows an increase in growth fractionR Przemioslo, N A Wright, G Elia, et al.
Journal of Clinical Pathology|August 1, 1994
Pitfalls in diagnosing coeliac diseaseR G Shidrawi, R Przemioslo, D R Davies, et al.
Addiction Biology|January 7, 2016
Carbohydrate deficient transferrin in alcoholic and non-alcoholic liver disease: a comparison of two assay methodsJ Keating, C Cheung, T J Peters, et al.
Scandinavian Journal of Gastroenterology|August 1, 1995
In vitro toxicity of gluten peptides in coeliac disease assessed by organ cultureR G Shidrawi, P Day, R Przemioslo, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1996
Cognitive impairments of alcoholic cirrhotic patients: correlation with endogenous benzodiazepine receptor ligands and increased affinity of platelet receptorsF Kapczinski, H V Curran, R Przemioslo, et al.
Gut|May 1, 1996
A duodenal mucosal abnormality in the reduction of Fe(III) in patients with genetic haemochromatosisK B Raja, D Pountney, A Bomford, et al.
Alimentary Pharmacology & Therapeutics|April 28, 2005
Multicentre randomized-controlled clinical trial of Ipocol, a new enteric-coated form of mesalazine, in comparison with Asacol in the treatment of ulcerative colitisA Forbes, A Al-Damluji, S Ashworth, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 2, 2009
Use of risedronate to prevent bone loss following a single course of glucocorticoids: findings from a proof-of-concept study in inflammatory bowel diseaseM H Kriel, J H Tobias, T J Creed, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Endoscopy|January 9, 2001
The effects of a preassessment clinic on nonattendance rates for day-case colonoscopyJ A Tibble, I Forgacs, I Bjarnason, et al.
Annals of Clinical Biochemistry|February 17, 1998
The effect of benign and malignant liver disease on the tumour markers CA19-9 and CEAS Maestranzi, R Przemioslo, H Mitchell, et al.
Gut|January 1, 1995
Analysis of crypt cell proliferation in coeliac disease using MI-B1 antibody shows an increase in growth fractionR Przemioslo, N A Wright, G Elia, et al.
Journal of Clinical Pathology|August 1, 1994
Pitfalls in diagnosing coeliac diseaseR G Shidrawi, R Przemioslo, D R Davies, et al.
Addiction Biology|January 7, 2016
Carbohydrate deficient transferrin in alcoholic and non-alcoholic liver disease: a comparison of two assay methodsJ Keating, C Cheung, T J Peters, et al.
Scandinavian Journal of Gastroenterology|August 1, 1995
In vitro toxicity of gluten peptides in coeliac disease assessed by organ cultureR G Shidrawi, P Day, R Przemioslo, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1996
Cognitive impairments of alcoholic cirrhotic patients: correlation with endogenous benzodiazepine receptor ligands and increased affinity of platelet receptorsF Kapczinski, H V Curran, R Przemioslo, et al.
Gut|May 1, 1996
A duodenal mucosal abnormality in the reduction of Fe(III) in patients with genetic haemochromatosisK B Raja, D Pountney, A Bomford, et al.
Alimentary Pharmacology & Therapeutics|April 28, 2005
Multicentre randomized-controlled clinical trial of Ipocol, a new enteric-coated form of mesalazine, in comparison with Asacol in the treatment of ulcerative colitisA Forbes, A Al-Damluji, S Ashworth, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 2, 2009
Use of risedronate to prevent bone loss following a single course of glucocorticoids: findings from a proof-of-concept study in inflammatory bowel diseaseM H Kriel, J H Tobias, T J Creed, et al.
Pageof 1